AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 281: H14-H21, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bürger, A.
Right arrow Articles by Zimmer, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bürger, A.
Right arrow Articles by Zimmer, H.-G.
Vol. 281, Issue 1, H14-H21, July 2001

Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts

Antje Bürger, Markus Benicke, Alexander Deten, and Heinz-Gerd Zimmer

Carl-Ludwig-Institut für Physiologie, Universität Leipzig, D-04103 Leipzig, Germany


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Proinflammatory cytokines have been implicated in the pathophysiology of different heart diseases. Recent evidence suggests that interleukin-6 (IL-6) may play a role in mechanisms leading to cardiac hypertrophy. In addition, catecholamines are known to induce cardiac hypertrophy. In the present study, we examined whether cardiac fibroblasts may be a potential source of IL-6 production in the rat heart and whether catecholamines can modulate the IL-6 synthesis. Only a small amount of IL-6 mRNA was detected in unstimulated rat cardiac fibroblasts. However, a 50-fold increase of IL-6 mRNA was found after stimulation with norepinephrine (NE). Addition of carvedilol, a alpha - and beta -adrenergic receptor antagonist, prevented almost completely the NE-induced synthesis of IL-6 mRNA. Phenylephrine, an alpha -adrenergic agonist, and isoproterenol, a beta -adrenergic agonist, also induced an increase in IL-6. However, the stimulation via beta -receptors led to a more pronounced elevation. These data show that NE increases IL-6 expression in rat cardiac fibroblasts and that IL-6 may play an important autocrine/paracrine role in cardiac disease states associated with hypertrophy.

cytokines; norepinephrine; cardiac hypertrophy; adrenergic receptor blocker


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

CYTOKINES, in particular interleukin 6 (IL-6), are highly potent, pleiotropic, endogenous peptides produced by a variety of cells. IL-6 has a broad range of activities, affecting not only initiation of primary host responses and tissue repair, but also homeostatic and neuroendocrine functions. IL-6 has both differentiation- and growth-promoting effects on a variety of target cells. For example, it is a B-cell stimulatory factor inducing terminal differentiation and high level antibody production (IL-6/BSF-2) (18, 25). IL-6 promotes growth of B-myeloma cells and T lymphocytes as well as T-cell differentiation (25, 39), but it inhibits growth of primary rat hepatocytes in culture (30). IL-6 stimulates growth of hemopoietic stem cells (43). It is a mediator of inflammation and a major alarm hormone signaling tissue damage and infection to the body's host defense system, in particular to the liver, where it induces the synthesis of acute phase plasma proteins (25).

Recent evidence suggests that proinflammatory cytokines are capable of modulating cardiovascular function by a variety of mechanisms, including promotion of left ventricular remodeling (31, 35), induction of contractile dysfunction (10, 45), and uncoupling of myocardial beta -adrenergic receptors (11, 16).

The cardiovascular effects of IL-6 are not well studied. There are some clinical data showing that serum levels of IL-6 were elevated in patients with mild or moderate heart failure (28) as well as in patients with acute myocardial infarction (21, 27). In a rat model of myocardial infarction, not only the IL-6 gene expression but also the tumor necrosis factor-alpha (TNF-alpha ) and IL-1beta gene expression were increased in the infarcted region (34). These results suggest that IL-6 may be both an acute-phase reactant and a chronic marker of inflammation associated with myocardial damage. A couple of reports have described a hypothesis that IL-6 may exert a negative inotropic effect and an intracellular Ca2+ concentration-lowering effect through nitric oxide-cGMP pathways in cultured chicken embryonic ventricular myocytes, in isolated hamster papillary muscles (10, 24), and in adult rat cardiac myocytes (38). Recent evidence suggests that IL-6 may play a role in mechanisms of heart hypertrophy: transgenic mice overexpressing IL-6 and IL-6 receptor developed hypertrophy of ventricular myocardium (19). In another model of cardiac hypertrophy due to pressure overload in rats, IL-6 was significantly increased (36).

In the present study we tested the effect of norepinephrine (NE) on IL-6 synthesis in rat cardiac fibroblasts, because it had been previously described that NE induced left ventricular hypertrophy in a rat model (46). We examined whether fibroblasts of rat hearts are able to synthesize IL-6 and whether NE can modulate IL-6 expression in these cells. We found that the abundance of IL-6 mRNA was low in rat cardiac fibroblasts and that catecholamines led to a marked increase in IL-6 mRNA mainly via beta -adrenergic receptors.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cultivation of cardiac fibroblasts. Cardiac fibroblasts from adult female Sprague-Dawley rats (200-250 g body wt) were isolated using a modification of a previously described protocol (8, 23). Briefly, rats were anesthetized with ether, and the chest was opened. The heart was immediately arrested by chilling with ice-cold 0.9% saline solution. The ascending aorta was cannulated, and the heart was excised and perfused with 15 ml of sterile Tyrode solution (in mM: 137 NaCl, 5.4 KCl, 0.5 MgCl2, 1.8 CaCl2, 11,6 HEPES, and 5 glucose; pH 7.35). The ventricle, free from the atrium, was minced and incubated with 0.1% trypsin and 300 U/ml collagenase type IV (Sigma; Deisenhofen, Germany) in a 37°C shaking water bath. Isolated cells were plated at the end of each 10-min digestion period. After five digestion periods, all isolated cells were combined and resuspended in Dulbeco's modified Eagle's-Ham's F-12 medium (DMEM-Ham's F-12 medium, Biochrom; Berlin, Germany), supplemented with 10% heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, and 100 µg of streptomycin (Biochrom) and plated in two wells of a six-well culture plate (Nunc; Rosklide, Denmark). After a 2-h incubation period at 37°C in an atmosphere at 5% CO2-95% air, the unattached cells were removed, and the attached cells (mostly fibroblasts) were grown. Confluent cells were subcultivated after removal with trypsin-EDTA 10× (Biochrom) diluted 1:10 in phosphate-buffered salt solution (PBS), pH 7.4. The cells were passed every 4 days. All experiments were performed using cells of passages 3 to 4. Cardiac fibroblasts were identified by 1) characteristic morphology, 2) positive immunofluorescence staining with antibodies to vimentin, as previously described (8), and 3) negative immunofluorescence staining with anti-human factor VIII. One day before the experiments were started, the cells were transferred to FCS-free medium to exclude the effects of cytokines possibly present in the FCS.

For stimulation, NE (Sigma) was dissolved at a concentration of 10 mmol/l in DMEM containing 100 mmol/l L-(+)-ascorbic acid (Merck; Darmstadt, Germany) to prevent oxidation and then diluted 1:1,000 in DMEM to obtain a final solution of 10 µmol/l, if not stated otherwise. Metoprolol (ME, CIBA-Geigy; Wehr, Germany) was also dissolved at a concentration of 10 mM in DMEM and then diluted 1:1,000 in DMEM to obtain a final solution of 10 µmol/l. Carvedilol (Boehringer Mannheim; Mannheim, Germany) was dissolved at a concentration of 6 mmol/l in DMEM containing 0.5% acetic acid and 5% dimethylformamide and then diluted to obtain the final solutions as indicated. Phenylephrine (PE) and isoproterenol (Iso, Sigma) were dissolved in DMEM at the concentrations indicated in the text.

RNA extraction and hybridization. Cardiac fibroblasts (106) were washed in PBS, and RNA was extracted by acid guanidium isothiocyanate-phenol-chloroform according to the method of Chomczynski and Sacchi (6). The total amount of RNA was quantitated based on its absorption at 260 nm. Twenty micrograms of total RNA were electrophoresed in an 1.2% agarose gel with 2.2 M formaldehyde, transferred to nylon membranes (Qiagen; Hilden, Germany) by vacuum blotting in 20× SSC (NaCl 1.5 M, sodium citrate 0.15 M, pH 7.0), and cross linked by ultraviolet illumination (UV Stratalinker, Stratagene; Heidelberg, Germany) at 254 nm for 2 min. After blotting, the filters were rinsed and prehybridized in Church buffer (sodium phosphate 0.25 M, pH 7.2, 5 mM EDTA, and 7% SDS) (7) for 2 h at 60°C. cDNA probe for IL-6 (see Generation of the IL-6 cDNA probe by RT-PCR) was labeled using a random priming kit (Boehringer) following the instructions given by the manufacturer. The labeled probe was added to the filters and hybridized overnight at 60°C. After hybridization, the membranes were washed in 2× SSC (0.15 mol/l sodium chloride and 0.015 mol/l sodium citrate adjusted to pH 7.0) with 1% SDS, followed by 0.2× SSC with 1% SDS both for 10 min at the same temperature as the hybridization was performed. The filters were exposed to Kodak X-Omat at -80°C for different times, depending on the signal intensity. Relative mRNA levels were determined by densitometric scanning (Elscript 400, Hirschmann Gerätebau; Unterhaching, Germany).

Generation of the IL-6 cDNA probe by RT-PCR. To detect IL-6 mRNA with Northern blotting, a cDNA probe for IL-6 was made by RT-PCR using primers corresponding to the IL-6 DNA sequence. Primers (gift from Dr. K. Thalmeier, Munich, Germany) generated a 617-bp fragment from the IL-6 sequence: sense (22 mer), 5' GCC TTC CCT ACT TCA CAA GTC C 3'; antisense (22 mer), 5' CTG ACC ACA GTG AGG AAT GTC C 3'. This fragment was cloned in the pGEMT-Vektor (see Fig. 3).

Total RNA was isolated from rapidly frozen rat heart using the method described above. First-strand cDNA synthesis and PCR were performed as previously described (41). Amplification was done in a DNA Thermal cycler as the following: initial denaturation at 94°C for 5 min, 30 cycles of amplification (94°C for 1 min, 65°C for 1 min, 72°C for 1 min), and final extension at 73°C for 5 min. DNA fragments were purified by separation in 1% agarose gel, cloned in the pGEM-T Vector (Promega; Heidelberg, Germany), and sequenced from both strands.

Ribonuclease protection assay. Ribonuclease protection assay was performed using a RiboQuantkit obtained from Pharmingen (Hamburg, Germany) following the instructions given by the manufacturer. Briefly, 2-5 µg of total RNA were hybridized with radioactive-labeled riboprobes from the PharMingen Multi-Probe Template Sets at 56°C for 12-16 h. After a RNase treatment, remaining "RNase-protected" probes were purified, resolved on denaturing polyacrylamide gels, and quantified by phosphorimaging (Bio-Rad; Munich, Germany). In addition to the samples, a dilution of the labeled probe set of cytokines was loaded on each gel to serve as size markers. The template probes (the markers) have the following size: IL-1alpha , 432 bp; IL-1beta , 390 bp; TNF-beta , 351 bp; IL-3, 315 bp; IL-4, 285 bp; IL-5, 255 bp; IL-6, 231 bp; IL-10, 210 bp; TNF-alpha , 189 bp; IL-2, 171 bp; interferon (IFN-gamma ), 158 bp; L32, 141 bp, and GAPDH, 126 bp. The protected IL-6 probe contained 202 bp. Data were corrected for the respective GAPDH (protected probe: 97 bp) and L32 (protected probe: 112 bp) values. The relative increase in abundance of IL-6 mRNA was calculated as a x-fold increase over the respective medium control. Because there was never a difference between the x-fold increase data when corrected for GAPDH or for L-32, only the GAPDH corrected values are presented.

Estimation of cell number. To estimate the cell number, a staining procedure was used based on the uptake of crystal violet into the cells and measuring the optical density of extracted dye (41). The adherent cells were washed in serum-free medium and fixed with 1% glutaraldehyde (15 min, room temperature). After being washed three times in distilled water, the cells were air dried at 37°C. Crystal violet (Sigma) was dissolved in 200 mmol/l boric acid, and the pH was adjusted to 9.0 with NaOH; the final concentration of crystal violet was 0.1%. A total of 200 µl of cristal violet solution were added per well. After an incubation for 20 min at room temperature, the solution was removed, and the cells were washed three times with distilled water and air dried at 37°C. The dye was extracted with acetic acid (10% vol/vol). The solution was transferred to a 96-well microtiter plate, and optical density was determined in an ELISA reader (Canberra Packard; Dreieich, Germany) at 570 nm. Standard curves with a defined cell number showed a linear correlation between the optical density (570 nm) and the cell number in the range from 1 × 104 to 1 × 105 cells.

Determination of IL-6 protein. Cardiac fibroblasts were seeded in 12-well culture plates and incubated with different stimuli. After various times, cell supernatants were removed, and IL-6 activity was determined by measuring the growth rate of the IL-6-dependent B9 cells (DSMZ; Braunschweig, Germany). Cells of the hybridoma line B9 (1) were cultured in RPMI containing L-glutamine, 2-mercaptoethanol (5 × 10-5 M), recombinant rat IL-6 (50 pg/ml) (recIL-6), and 10% FCS (B9 medium). Cells were centrifuged twice in B9 medium without recIL-6, adjusted to 2 × 104 cells/ml, and 100 µl of this cell suspension were cultured for 72 h at 37°C in 96-well microtiter plates (Greiner; Frickenhausen, Germany) with 10 µl of various dilutions of supernatants from stimulated fibroblasts. The proliferation of the cells was assessed by a MTT-based Cell Proliferation Kit I (Boehringer Mannheim) following the instructions given by the manufacturer. A standard proliferation curve was obtained with recombinant rat IL-6 (BioConcept; Umkirch, Germany), absorbance values were compared with those of the standard curve, and the concentration of IL-6 was extrapolated. Values were expressed in picograms per milliter of supernatant of ~6 × 104 fibroblasts measured from crystal violet staining.

Statistical analysis. Comparisons between means were made by using Student's t-test or nonparametric Wilcoxon test, respectively.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of NE on cytokine gene expression by cardiac fibroblasts. In a first set of experiments, the effect of NE on gene expression of various cytokines in rat cardiac fibroblasts was tested by the RNase Protection Assay. Ten different cytokines were tested with the same RNA sample. Unstimulated cardiac fibroblasts expressed a weak or undetectable message for IL-1alpha and -beta , TNF-beta , IL-3, IL-4, IL-5, IL-6, IL-10, TNF-alpha , IL-2, and IFN-gamma . After NE (10 µmol/l) was added, an increase in abundance of only IL-6 mRNA was obtained within 1-2 h (Fig. 1). Enhanced signals for IL-6 mRNA were first detected at 30 min upon stimulation, peaked at 2 h, and returned near control levels after 8 h (Table 1). Depending on different donor hearts, the number of cell passages, and also cell density, a 16- to 71-fold increase of IL-6 mRNA was seen after stimulation with 10 µM NE for 2 h compared with unstimulated cells. The same kinetics, but lower values, were obtained after addition of 5 µmol/l NE (data summarized in Table 1). The other cytokine mRNAs were not detectable even after prolonged periods of culture time. The NE-induced stimulation was dose dependent. With 40 µmol/l NE, a 110-fold increase of IL-6 mRNA was observed within 2 h compared with unstimulated cells. Because the relative increase in the abundance of IL-6 mRNA depends on culture conditions, Fig. 2 shows the results of a representative experiment.


View larger version (79K):
[in this window]
[in a new window]
  		Fig. 1.   Cytokine mRNA synthesis in rat cardiac fibroblasts after stimulation with norepinephrine (NE). A ribonuclease protection assay (RPA) is shown. Cells (5 × 105) were cultivated in the presence of medium alone (-) or 10 µmol/l NE (+) for the time periods indicated. Total RNA was then isolated and specific cytokine mRNA was determined by RPA. Last lane represents a dilution of the labeled probe set to serve as a size marker. IL, interleukin; TNF, tumor necrosis factor; IFN, interferon.


                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Effect of norepinephrine on IL-6 mRNA in cardiac fibroblasts



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 2.   Dose-dependent induction of IL-6 mRNA synthesis by NE. Cells were incubated for 2 h with NE at the indicated concentration. Total RNA was then isolated, and IL-6 mRNA was determined by RPA. Relative increase in abundance of specific cytokine mRNA was calculated by phosphorimaging, and data were corrected for the value obtained for GAPDH. Data represent x-fold increase over unstimulated cells.

Effect of NE on IL-6 mRNA. To investigate the NE-induced IL-6 mRNA in more detail, Northern blot analysis was done using a rat cDNA sequence specific for IL-6 (Fig. 3). In unstimulated fibroblasts, only weak IL-6 mRNA was detected, whereas an increase in abundance of IL-6-specific mRNA was seen after adding NE (5 µmol/l) (Fig. 3). Northern blot analysis of total RNA extracted from NE-stimulated cells revealed two size classes of IL-6 mRNA (32): a "major" class of 1.2-1.3 kb and a "minor" class of 2.4 kb. As assessed by quantitative densitometry of the autoradiographs, the major class was approximately two to three times more abundant than the minor class.


View larger version (44K):
[in this window]
[in a new window]
  		Fig. 3.   IL-6 mRNA determined by Northern blotting. Left: RT-PCR product (lane 1, lane M shows DNA 100-bp marker). Right: Northern blot using the PCR product as probe. Rat cardiac fibroblasts were cultivated in the presence of medium alone (-) or 5 µmol/l NE (+) for 2 h. Total RNA was then isolated and IL-6 specific mRNA was determined by Northern blotting. The size of the two IL-6 mRNA bands is indicated on right.

Analysis of NE-induced IL-6 synthesis via alpha - and beta -adrenergic receptors. To assess whether the NE-induced increase in IL-6 mRNA is mediated by adrenergic receptors, the effect of carvedilol, a alpha - and beta -antagonist, was tested. Carvedilol inhibited almost completely the NE-induced increase in abundance of IL-6 mRNA (Fig. 4, data of different experiments are summarized in Table 2). Different concentrations of carvedilol were tested; maximum inhibition was already seen at a concentration of 5 µmol/l and was not further influenced with increased doses of carvedilol. Carvedilol alone had no effect on IL-6 mRNA.


View larger version (63K):
[in this window]
[in a new window]
  		Fig. 4.   Effect of carvedilol (CA) and metoprolol (ME) on NE-induced IL-6 mRNA. Left panel: effect of CA. Cells were cultivated in the presence of medium alone (lane 2; CA -, NE -), 10 µmol/l CA alone (lane 3; CA +, NE -), 10 µmol/l NE in combination with 10 µmol/l CA (lane 4; CA +, NE +), or in the presence of 10 µM NE (lane 5; CA -, NE +) for 2 h. Total RNA was isolated and cytokine mRNA was determined by RPA. First lane represents a dilution of the labeled probe set to serve as a size marker. Protected IL-6-specific mRNA band, two protected L32-specific mRNA bands, and three GAPDH bands are shown on the right side of the panel. Right panel: effect of ME. Cells were cultivated in the presence of medium alone (lane 1; ME -, NE -), 10 µmol/l metoprolol (lane 2; ME +, NE -), 10 µmol/l NE in combination with 10 µmol/l ME (lane 3; ME +, NE +), or in the presence of 10 µmol/l NE (lane 4; ME -, NE +) for 2 h. Total RNA was isolated and cytokine mRNA was determined by RPA. Last lane represents a dilution of the labeled probe set to serve as a size marker. Protected IL-6-specific mRNA band, two protected L32-specific mRNA bands, and three GAPDH bands are shown on the left side of the panel.


                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Effect of carvedilol and metoprolol on norepinephrine-induced IL-6 mRNA in rat cardiac fibroblasts

To determine the alpha - and beta -adrenergic selectivity for NE-mediated IL-6 synthesis, various agonists and antagonists were tested. Both the beta -selective agonist Iso and the alpha -agonist PE induced an increase in abundance of IL-6 mRNA, whereas no other cytokine mRNA was upregulated (Fig. 5). The effect of Iso was more prominent; when fibroblasts were stimulated with 10 µmol/l Iso, a 29-fold (±1.5; n = 3; P < 0.05) increase was observed after 2 h. Addition of 10 µmol/l PE led to an increase in IL-6 mRNA of about 12-fold (±1.63; n = 3; P < 0.05) over unstimulated cells. To see whether stimulation of cardiac fibroblasts with either of these agonists or with NE affected IL-6 mRNA synthesis with the same kinetic, cells were cultivated with PE, Iso, or NE for different periods of time. In these experiments, the most abundant increase in IL-6 mRNA was also found after 2 h of stimulation (Fig. 5).


View larger version (45K):
[in this window]
[in a new window]
  		Fig. 5.   Effects of NE, phenylephrine (PE), and isoproterenol (Iso) on IL-6 mRNA. Left panel: an RPA is shown. Cells were cultivated for 2 h in presence of 10 µmol/l NE (lane 2), 10 µmol/l PE (lane 3), 10 µmol/l Iso (lane 4), or in the presence of control medium (CO) (last lane). Total RNA was isolated and cytokine mRNA was determined by RPA. First lane represents a dilution of the labeled probe set to serve as a size marker. Protected IL-6-specific mRNA band, two protected L32-specific mRNA bands, and three GAPDH bands are shown on the right side of the panel. Right panel: time course of the effect of PE, Iso, and NE on IL-6 mRNA. Cells were incubated with 10 µmol/l NE, 10 µmol/l PE, or with 10 µmol/l Iso for the time periods indicated. Total RNA was isolated and cytokine mRNA was determined by RPA. Relative increase in abundance of specific cytokine mRNA was calculated by phosphorimaging, and data were corrected for the value obtained for GAPDH. Data represent x-fold increase over unstimulated cells.

Consistent with an effect of Iso mediated through beta -adrenergic receptors, the effect of NE-induced IL-6 mRNA was attenuated by the beta -antagonist ME (Fig. 4; Table 2). Various concentrations of ME were tested: the maximum of inhibition was already obtained at 10 µM ME and could not further be influenced with 30 µM ME. Within this range of ME, an up to 91% inhibition of NE-induced IL-6 mRNA synthesis was obtained.

Effect of NE on IL-6 protein synthesis. To examine whether the increase in IL-6 mRNA also resulted in an increased protein synthesis, IL-6 protein was determined in the cell supernatant by means of a bioassay. Cardiac fibroblasts were stimulated with NE (10 µmol/l) and for comparison fibroblasts were stimulated with TNF-alpha (10 ng/ml) and with platelet-derived growth factor (PDGF) (10 ng/ml) for various periods of time. The cell supernatants were harvested and added to B9 cells. With supernatants from unstimulated cells and from cells stimulated with TNF-alpha , only minimal proliferation was induced, whereas NE led to a 10-fold increase and PDGF led to a 3- to 4-fold increase in IL-6 activity compared with cells that had been cultured with medium alone (Fig. 6). In another set of experiments, IL-6 protein was detected by SDS-PAGE and Western blotting (data not shown).


View larger version (33K):
[in this window]
[in a new window]
  		Fig. 6.   Effect of NE, platelet-derived growth factor (PDGF), and TNF-alpha on IL-6 protein. Cells were stimulated with either 10 µM NE, PDGF (10 ng/ml), TNF-alpha (10 ng/ml), or with medium alone for the time periods indicated. Cell supernatants were harvested, and IL-6 activity was determined by B9 bioassay. Values represent IL-6 (pg/ml) per 6 × 104 cells. Number of experiments is given in parentheses. *P < 0.05 vs. medium control.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

It is well known that catecholamines induce cardiac hypertrophy (46, 20). It was shown that DNA content increased in rat hearts after NE treatment (46). Because cardiomyocytes are end-differentiated cells, this effect could either be the result of polyploidy or the proliferation of fibroblasts. Fibroblasts are also responsible for the accumulation of extracellular matrix proteins, which was also observed during cardiac hypertrophy (8, 5, 42). Therefore, fibroblasts seem to be the cell type in the heart that modulates a variety of cardiac functions. For example, it has been shown that angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from cardiac fibroblasts in a neonatal rat cell culture model (15). With regard to recent findings that proinflammatory cytokines are capable of modulating cardiovascular function, we investigated whether cardiac fibroblasts in culture expressed cytokines, in particular IL-6, and whether NE can modulate this cytokine synthesis. Among a variety of cytokines tested, only a weak amount of IL-6 mRNA was detected in unstimulated cells. Upon incubation of fibroblasts with NE, a rise in IL-6 mRNA was seen. There was a variation of the extent of stimulation, from 10-fold as a minimal increase to a maximal increase of 71-fold, when independent experiments were compared. An average 49-fold increase was seen after 2 h. The fact that primary cultures of cells of different donor rats were used might explain the differences. In addition, although not yet studied in detail, cell density and number of passages appear to affect IL-6 mRNA synthesis. Whether the increase of IL-6 mRNA is transcriptionally mediated or regulated on the mRNA level remains to be determined. These data were in line with first in vivo data showing that IL-6 mRNA and protein were increased in rat hearts after l-isoproterenol treatment (29) and within hours after administration of NE (2). However, fibroblasts were perhaps not the only cell type participating in the increased IL-6 mRNA of hypertrophied rat hearts. Cardiac myocytes have been shown to express IL-6, for example, after hypoxic stress (44) or after stimulation with cytokines (17).

To obtain more information about the structure of the IL-6 mRNA, Northern blot analysis was performed. Again, in unstimulated rat cardiac fibroblasts only a weak amount of IL-6 mRNA was detected, whereas stimulation with NE revealed a marked increase in IL-6 mRNA. As described by others (32), two IL-6-specific mRNA bands were detected, one of about 1.2 kb and another of about 2.4 kb length. As assessed by quantitative densitometry, the 1.2-kb mRNA was two to three times more abundant than the 2.4-kb mRNA. Human and murine IL-6 mRNA appears as a single band in the 1.2- to 1.3-kb size range on Northern blots. The presence of a separate 2.4-kb mRNA is a unique property of rat cells. The reason for this phenomena is not the presence of two different IL-6 genes, but is the consequence of the existence of alternative polyadenylation sites. The murine and human IL-6 genes also contain two polyadenylation sites, but the distance between these sites is shorter than in rats because of the longer version of exon 5 of the rat IL-6 gene, which results in a 1.2-kb longer mRNA (32). Whether the mRNA species generated by different polyadenylation have different structural or functional properties, such as mRNA folding, mRNA half-life, transport, or translation efficiency is not known to date.

Since it was previously described that stimulatory effects of catecholamines are not always mediated by adrenergic receptors (22, 14), it was examined whether the NE-induced increase in IL-6 mRNA was mediated by adrenergic receptors. As shown in Fig. 4, carvedilol, an alpha - and beta -antagonist, inhibited almost completely the NE-induced increase in abundance of IL-6 mRNA, indicating that the stimulatory effect of catecholamines was clearly mediated by adrenergic receptors. To determine whether it is caused by alpha - or beta -adrenergic receptors, the effect of PE and Iso was tested. Both agonists increased the IL-6 mRNA with the same kinetics as did NE, but Iso led to a more pronounced increase than PE in our culture conditions. Consistent with these data is that addition of ME, a selective beta -receptor antagonist, markedly attenuated the NE-induced increase in IL-6 mRNA. So it seems that the catecholamine-induced increase in IL-6 mRNA may be mainly mediated by beta -adrenergic receptors. Because PE also increased the IL-6 mRNA, further experiments are required to assess a possible synergistic effect when both receptors are stimulated. It is well known and recently confirmed (4) that beta -blockers have a beneficial effect on ventricular function and remodeling in patients with mild or moderate heart failure. Because it is also known that serum levels of IL-6 were elevated in these patients, it might be possible that the beneficial effect of beta -blockers is partially due to the inhibition of cytokine expression in the heart, especially IL-6.

The increase in mRNA also resulted in an increase in IL-6 protein. In the cell supernatants, up to a 10-fold increase in IL-6 protein was seen within 8 h compared with that seen in unstimulated cells. There was a variation with regard to the extent of stimulation when independent experiments were compared. These differences may be explained by the fact that a bioassy was used as a test system and that fibroblast cell density may affect IL-6 protein synthesis (13). To the best of our knowledge, this is the first report showing that rat cardiac fibroblasts are able to synthesize IL-6. For comparison, the effect of PDGF and TNF-alpha was also tested. These two substances are well-known stimuli of the IL-6 synthesis in fibroblasts from other organs and other cell species (9, 13, 40). Under our culture conditions, however, TNF-alpha did not stimulate IL-6 protein release in rat cardiac fibroblasts. PDGF had a moderate effect, whereas the most pronounced increase was obtained with NE.

In a number of pathophysiological conditions leading to cardiac hypertrophy, the activity of the sympathetic nervous system is enhanced, resulting in the increased release of NE from the sympathetic nerve endings within the myocardium (33). Furthermore, administration of catecholamines can induce cardiac hypertrophy (20, 46). However, the biological or pathophysiological role of the NE-induced IL-6 synthesis in this context is not well known. Because it was recently described that IL-6, mostly in combination with the soluble IL-6 receptor, increased different extracellular matrix proteins (3), as well as the expression of collagenases and tissue inhibitors of metalloproteinases in different cell types (12, 26), IL-6 may participate in remodeling of the extracellular matrix. The growth-promoting effect of IL-6 is also well documented (1, 13, 47) so that this cytokine may be involved in the induction of cell proliferation observed during NE-induced cardiac hypertrophy (46). In addition, the fact that neonatal mice as well as adult cat cardiomyocytes enlarged in response to a combination of IL-6 and a soluble form of IL-6 receptor (19, 37) also emphasizes a possible role of IL-6 in cardiac hypertrophy.

Taken together, IL-6 appears to be a possible mediator of cardiac hypertrophy; possible sources of IL-6 in vivo are cardiomyocytes (17, 44) and, as we have now shown, also fibroblasts.


    ACKNOWLEDGEMENTS

The excellent technical assistance of B. Mix is gratefully acknowledged.


    FOOTNOTES

These studies were supported by the Deutsche Forschungsgemeinschaft (Zi 199/10-1) and, in part, by a grant of the Medical Faculty of the University of Leipzig (78651104).

Address for reprint requests and other correspondence: A. Bürger, Carl-Ludwig-Institut für Physiologie, Liebigstrasse 27, D-04103 Leipzig, Germany.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 6 June 2000; accepted in final form 19 February 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Aarden, LA, De Groot ER, Schaap OL, and Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411-1416, 1987[ISI][Medline].

2.   Barth, W, Deten A, Bauer M, Reinohs M, Leicht M, and Zimmer HG. Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 32: 273-284, 2000[ISI][Medline].

3.   Bodo, M, Carinci F, Baroni T, Giammarioli M, Belluci C, Bosi G, Pezetti F, Becchett E, Evangelisti R, and Carinci P. Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins. Eur J Clin Invest 27: 36-42, 1997[ISI][Medline].

4.   Bristow, MR. beta -Adrenergic receptor blockade in chronic heart failure. Circulation 101: 558-569, 2000[Free Full Text].

5.   Butt, RP, Laurent GJ, and Bishop JE. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol 68: 330-335, 1995[ISI][Medline].

6.   Chomczynski, P, and Sacchi N. Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987[ISI][Medline].

7.   Church, GM, and Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984[Abstract/Free Full Text].

8.   Eghbali, M, Tomek R, Sukhatme VP, Woods C, and Bhambi B. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts: regulation of fibrillar collagen RNAs and expression of early transcription factors. Circ Res 69: 483-490, 1991[Abstract/Free Full Text].

9.   Elias, JA, and Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messanger RNA. J Immunol 145: 161-166, 1990[Abstract].

10.   Finkel, MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, and Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992[Abstract/Free Full Text].

11.   Fowler, MB, Laser JA, Hopkins GL, Minobe W, and Bristow MR. Assessment of the beta -adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290-1302, 1986[Abstract/Free Full Text].

12.   Franchimont, N, Rydziel S, Delany AM, and Canalis E. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. J Biol Chem 272: 12144-12150, 1997[Abstract/Free Full Text].

13.   Fries, KM, Felch ME, and Phipps RP. Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am J Respir Cell Mol Biol 11: 552-560, 1994[Abstract].

14.   Furukawa, Y, Tomioka N, Sato W, Satoyoshi E, Hayashi K, and Furukawa S. Catecholamines increases nerve growth factor mRNA content in both mouse astroglial and fibroblast cells. FEBS Lett 247: 463-467, 1989[ISI][Medline].

15.   Gray, MO, Long CS, Kalinyak JE, Li HT, and Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40: 352-363, 1998[Abstract/Free Full Text].

16.   Gulick, T, Chung MK, Pieper SJ, Lange LG, and Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86: 6753-6757, 1989[Abstract/Free Full Text].

17.   Gwechenberger, M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Micheal LH, and Entman ML. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99: 546-551, 1999[Abstract/Free Full Text].

18.   Hirano, T, Yasujawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu K, Tasunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, and Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobin. Nature 324: 73-76, 1986[Medline].

19.   Hirota, H, Yoshida K, Kishimoto T, and Taga T. Continuous activation of gp 130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862-4866, 1995[Abstract/Free Full Text].

20.   Harri, MNE Metabolic and cardiovascular response to prolonged noradrenaline load and their antagonism by beta blockade in the rat. Acta Physiol Scand 104: 402-414, 1978[ISI][Medline].

21.   Ikeda, U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, and Shimada K. Serum interleukin 6 levels elevated in acute myocardial infarction. J Mol Cell Cardiol 24: 570-584, 1992.

22.   Irlbeck, M, Mühling O, Iwai T, and Zimmer HG. Different response of the rat left and right heart to norepinephrine. Cardiovasc Res 31: 157-162, 1996[ISI][Medline].

23.   Iwami, K, Ashzawa N, Do YS, Graf K, and Hsueh WA. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 270: H2100-H2107, 1996[Abstract/Free Full Text].

24.   Kinugawa, KI, Takahashi T, Kohmoto O, Yao A, Aoyagi T, Momomura SI, Hirata Y, and Serizawa T. Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res 75: 285-295, 1994[Abstract/Free Full Text].

25.   Kishimoto, T, and Hirano T. Molecular regulation of B lymphocyte response. Annu Rev Immunol 6: 485-512, 1988[ISI][Medline].

26.   Lotz, M, and Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266: 2017-2020, 1991[Abstract/Free Full Text].

27.   Miyao, Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, and Morita E. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 126: 1299-1304, 1993[ISI][Medline].

28.   Munger, MA, Johnson B, Amber I, Callahan KS, and Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77: 723-727, 1996[ISI][Medline].

29.   Murray, DR, Prabhu SD, and Chandrasekar B. Chronic beta -adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101: 2338-2341, 2000[Abstract/Free Full Text].

30.   Nakamura, T, Arakaki R, and Ichihara A. Interleukin-1 beta is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp Cell Res 179: 488-497, 1988[ISI][Medline].

31.   Natanson, C, Eichenholz PW, Danner RL, Eichacker W, Hoffmann D, Kuo GC, Banks SM, MacVittie TJ, and Parrillo JE. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169: 823-832, 1989[Abstract/Free Full Text].

32.   Northemann, W, Braciak TA, Hattori M, Lee F, and Fey GH. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem 264: 16072-16082, 1989[Abstract/Free Full Text].

33.   Östman-Smith, I. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci (Colch) 61: 265-272, 1981[Medline].

34.   Ono, K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts. Circulation 98: 149-156, 1998[Abstract/Free Full Text].

35.   Pagani, FD, Baker LS, Hsi C, Knox M, Fink MP, and Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 90: 389-398, 1992.

36.   Pan, J, Fukuda K, Kodama H, Sano M, Takahashi T, Makino S, Kato T, Manabe T, Hori S, and Ogawa S. Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels 13: 199-208, 1998[ISI][Medline].

37.   Dibbs, Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Baumgarten G, Sivasubramanian N, and Mann DL. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians 111: 423-428, 1999[ISI][Medline].

38.   Suter, TM, Satoh N, Communal C, Liao R, and Apstein CS. Interleukin-6 decreases the frequency dependent contractility by attenuating calcium transients but not calcium handling proteins (Abstract). Circulation 98: I404, 1998.

39.   Takai, Y, Wong GG, Clark SC, Burakoff SJ, and Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140: 508-512, 1988[Abstract].

40.   Tiggelmann, AMBC, Boers W, Linthorst C, Brand H, Sala M, and Chamuleau RAFM Interleukin-6 production by human (myo) fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1beta and TNFalpha . J Hepatol 23: 295-306, 1995[ISI][Medline].

41.   Viedt, C, Bürger A, and Hänsch GM. Fibronectin synthesis in tubular epithelial cells: upregulation of the EDA splice variant by transforming growth factor beta . Kidney Int 48: 1810-1817, 1995[ISI][Medline].

42.   Weber, KT, and Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiontensin-aldosterone system. Circulation 83: 1849-1865, 1991[Abstract/Free Full Text].

43.   Wong, GG, and Clark SC. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9: 137-139, 1988[ISI][Medline].

44.   Yamauchi-Takihara, K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, and Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91: 1520-1524, 1995[Abstract/Free Full Text].

45.   Yokoyama, T, Vaca L, Rossen RD, Durante W, Hazarika P, and Mann DL. Cellular basis of the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92: 2302-2312, 1993.

46.   Zierhut, W, and Zimmer HG. Significance of myocardial alpha - and beta -adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1425, 1989[Abstract/Free Full Text].

47.   Zilberstein, A, Ruggieri R, Korn JH, and Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 5: 2529-2537, 1986[ISI][Medline].

Am J Physiol Heart Circ Physiol 281(1):H14-H21
0363-6135/01 $5.00 Copyright © 2001 the American Physiological Society


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
I. Mikaelian, D. Coluccio, K. T. Morgan, T. Johnson, A. L. Ryan, E. Rasmussen, R. Nicklaus, C. Kanwal, H. Hilton, K. Frank, et al.
Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat
Toxicol Pathol, February 1, 2008; 36(2): 256 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson
Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links
Cardiovasc Res, June 1, 2006; 70(3): 434 - 445.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. D. Faulx, P. Ernsberger, D. Vatner, R. D. Hoffman, W. Lewis, R. Strachan, and B. D. Hoit
Strain-dependent {beta}-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H30 - H36.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. Keller, C. Keller, L. E. Robinson, and B. K. Pedersen
Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans
J Appl Physiol, October 1, 2004; 97(4): 1309 - 1312.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. L. Lee, R. Leite, C. Fleming, J. S. Pollock, R. C. Webb, and M. W. Brands
Hypertensive Response to Acute Stress Is Attenuated in Interleukin-6 Knockout Mice
Hypertension, September 1, 2004; 44(3): 259 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Frost, G. J. Nystrom, and C. H. Lang
Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E809 - E817.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Gessler, J. Pfenninger, J.-P. Pfammatter, T. Carrel, O. Baenziger, and C. Dahinden
Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 718 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Plenz, H. Eschert, M. Erren, T. Wichter, M. Bohm, M. Flesch, H. H. Scheld, and M. C. Deng
The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1508 - 1512.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bürger, A.
Right arrow Articles by Zimmer, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bürger, A.
Right arrow Articles by Zimmer, H.-G.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online